Literature DB >> 12144081

Attention-deficit/hyperactivity disorder: an update.

Raymond Pary1, Susan Lewis, Paul R Matuschka, Steven Lippmann.   

Abstract

Attention-deficit/hyperactivity disorder, a syndrome involving inattention, impulsivity, and hyperactivity, was originally thought to occur only in children. It is now a recognized condition throughout life in some individuals. For a valid diagnosis, the onset of symptoms should occur before age 7. Dysfunction of catecholamine neurotransmission is implied by the clinical improvement induced by stimulants. Positron emission tomography studies reveal reduced glucose metabolism in the basal ganglia and sometimes in the frontal cortex. Excessive cortical slowing is documented on the electroencephalogram. Twin studies show a familial, genetic influence. Data from multiple sources are necessary for a diagnosis, and rating scales are particularly useful for the adult syndrome. Older individuals typically manifest disorganization and impulsivity more than hyperactivity. Stimulant drugs are the principal forms of treatment for all ages, but bupropion is favored for patients with substance abuse history.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12144081

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  2 in total

1.  A Comparison between School and Home Rating Scales and Reliability-Validity of the Scales-the Scales for Diagnosing Attention-Deficit/Hyperactivity Disorder.

Authors:  Ebru Aksu Meriçli; Figen Turan
Journal:  Noro Psikiyatr Ars       Date:  2014-09-01       Impact factor: 1.339

2.  Blood phospholipid fatty acid analysis of adults with and without attention deficit/hyperactivity disorder.

Authors:  Genevieve S Young; Nicole J Maharaj; Julie A Conquer
Journal:  Lipids       Date:  2004-02       Impact factor: 1.880

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.